The 20 Best Acute Myelomonocytic Leukemia Doctors Near Me in Baltimore, MD

Maria Baer is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Baer is rated as a Distinguished provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. She is also highly rated in 32 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Promyelocytic Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Splenectomy.

Mark J. Levis, M.D., Ph.D., professor of oncology, medicine and pharmacology in the Division of Hematologic Malignancies at the Johns Hopkins University School of Medicine, co-directs the Hematologic Malignancies and Bone Marrow Transplantation Program and directs the Adult Leukemia Service at the Johns Hopkins Sidney Kimmel Cancer Center. In addition to his role within the Kimmel Cancer Center, he serves on the faculty for the Johns Hopkins Graduate Training Program in Cellular and Molecular Medicine, a Ph.D. program that prepares scientists to conduct laboratory research at the cellular and molecular level that is designed to have a direct impact on the understanding of human diseases. Dr. Levis has expertise in acute and chronic myeloid leukemia, acute lymphoblastic leukemia, and myelodysplastic syndromes. Dr. Levis received his medical degree at the University of California, San Francisco School of Medicine, where he also earned his Ph.D. in Biochemistry. He completed a residency in internal medicine at Johns Hopkins, followed by fellowships in medical oncology. Dr. Levis is a member of the American Society of Hematology, the American Society of Clinical Oncology and the European Hematology Association. He is an ad hoc member of the Oncology Drug Advisory Committee, as well as an ad hoc manuscript referee for peer-reviewed journals such as New England Journal of Medicine; Leukemia; Clinical Cancer Research; and The American Journal of Hematology. Dr. Levis has earned numerous awards, such as the Daniel Nathans Research Award from Johns Hopkins University, the Osler Housestaff Teaching Award, the Director's Teaching Award in Clinical Science, and the Advanced Clinical Research Award from the American Society of Clinical Oncology. Dr. Levis’ laboratory research focuses on the development of molecularly-targeted therapies for leukemia. He is actively involved in the pre-clinical and clinical development of small molecule inhibitors of protein kinases, including FLT3. The research involves studying the biochemical effects of these inhibitors on samples taken from leukemia patients, with the broad goal of identifying and validating novel molecular therapeutic targets in these hematopoietic malignancies. While Dr. Levis plays a key role in the pre-clinical development of these therapies, he is particularly interested in translating this research to the bedside of his patients by using correlative studies to incorporate these novel therapies into existing treatments. In addition to his work in both the clinic and the laboratory, Dr. Levis has also conducted talks, mentorship and teaching lectures, and published extensively in the top journals in his field, including Leukemia; Blood; and the New England Journal of Medicine. Dr. Levis is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Promyelocytic Leukemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Dr. Ivana Gojo is a Hematologist/Oncologist in Baltimore. Her clinical focus is on diagnosis and management of patients with acute leukemias (AML, ALL) and other myeloid malignancies (MDS, MPNs, CML), with emphasis on the development of novel therapeutic approaches for these diseases. She is nationally and internationally recognized expert in clinical translation of novel therapeutics for acute leukemias and principal investigator on multiple multi-center investigator-initiated studies. Dr. Gojo joined the Johns Hopkins faculty in 2012 as the Co-Director of Leukemia Drug Development Program. She has served on the National Cancer Institute (NCI) Investigational Drug Steering Committee since 2014. Dr. Gojo received a Service Star Award from Johns Hopkins Medicine Service Excellence in 2018 for her exemplary care of leukemia patients. Dr. Gojo contributed to the clinical translational and drug development effort of multiple novel agents targeting pathogenic pathways in patients with acute leukemia. Her research efforts are now concentrated on the development and integration of novel immunotherapies into therapeutic armamentarium for patients with acute leukemia. She mentors basic and clinical research fellows and junior faculty on the development and design of novel clinical trials and mechanistic laboratory studies associated with these trials. She served as a leukemia team leader on the National Institute of Health (NIH)/NCI N01 grant (Phase II consortium) (2009-2011), and is co-principal investigator (PI) on the Experimental Therapeutics (ET)-Clinical Trial Network (CTN) UM1 grant supporting early clinical trials. Dr. Gojo has served on the National Comprehensive Cancer Network guideline panel for AML since 2019, Myeloid Growth Factor guideline panel since 2015 and previously served on the MPNs guideline panel (2016-2019). She has extensive experience in the regulatory aspects of drug development and served as the Chair (2015-2016) and Co-Chair (2014-2015) of the Cancer Research Review Committee at Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, and serves as a member of the SKCCC Biostatistics Core Advisory Committee and SKCCC Clinical Research Office Coordinating Center Oversight Committee. Dr. Gojo is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Gojo is board certified in American Board Of Internal Medicine.

Dr. Gabrielle Prince is an Oncologist in Baltimore caring for patients with leukemias and other blood and bone marrow disorders. She is viewed regionally as a clinical expert in the care of patients with these disorders and has served as the Principal Investigator for numerous clinical trials studying new treatments for the most challenging clinical cases. Dr. Prince received her undergraduate degree in Biomedical Engineering from Columbia University (New York, NY), earned her M.D. at the State University of New York (Brooklyn, NY), completed her Residency at Columbia University Medical Center-New York Presbyterian (New York, NY), and Fellowship in Medical Oncology at Johns Hopkins (Baltimore, MD). Dr. Prince joined the Johns Hopkins faculty in 2014 at the completion of her training. Her main research interests include drug development for patients with AML, MDS, and MPDs. She has been involved in several clinical trials that helped lead to FDA approval of those new drugs and she remains interested in helping the program maintain a broad-based clinical trials portfolio. Dr. Prince is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, Childhood Acute Myeloid Leukemia, and Bone Marrow Aspiration.

Dr. B. Douglas Smith is an Oncologist in Baltimore caring for patients with leukemias and other blood and bone marrow disorders and he is recognized nationally as an expert in the care of patients with these disorders and as a leader in novel therapeutics for these conditions. Dr. Smith serves as the Co-Director of Clinical Research Operations for the Division of Hematologic Malignancies and helps to manage the Division’s clinical research trials. Dr. Smith received his undergraduate degree in Biology from Lafayette College (Easton, PA), earned his M.D. at the Medical College of Pennsylvania (Philadelphia, PA), completed his Residency at Strong Memorial Hospital of the University of Rochester (Rochester, NY), and Fellowship in Medical Oncology at Johns Hopkins (Baltimore, MD). Dr. Smith joined the Johns Hopkins faculty in 1998 at the completion of his training. His main research interests include drug development for patients with AML, CML, and MDS and he serves as Co-Investigator for the Oncology Center’s UM1 (early phase drug development) Grant. The Leukemia Program’s clinical trials portfolio has included trials for each of the 8 newly FDA-approved drugs for acute leukemia in the past 2 years. Dr. Smith has a passion for teaching trainees and has served on the Fellowship Executive Committee since 2010 focusing on the program’s educational platforms. He has won numerous teaching awards in both the Department of Oncology and the Department of Medicine multiple times, and he has a track record of mentoring fellows pursuing clinical-translational research and clinician-educator pathways. In 2020, Dr. Smith was awarded membership in the prestigious Miller Coulson Academy for Excellence in Clinical Care. He is a member of the American Society of Hematology, the American Society of Clinical Oncology and the American Association for Cancer Research. He has served on the National Comprehensive Cancer Network guideline panel for CML since 2001 and previously served on the AML panel from 2001-2015. Dr. Smith has extensive experience in the regulatory aspects of drug development and he currently serves as the Chair of the Johns Hopkins Institutional Review Board #2. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration.

Steven Gore is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Gore is rated as an Advanced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Gore is board certified in Internal Medicine and Medical Oncology.

Vu Duong is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Duong is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Myringotomy.

Sandrine Niyongere is a Hematologist practicing medicine in Baltimore, Maryland. Dr. Niyongere is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Acute Myeloblastic Leukemia with Maturation, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Nancy Hardy is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Hardy is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.

Margaret Showel is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Showel is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Childhood Acute Myeloid Leukemia, and Bone Marrow Aspiration.

Michael Mcdevitt is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Mcdevitt is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Acute Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML), and Polycythemia Vera.

Judith Karp is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Karp is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Myelomonocytic Leukemia, and Chronic Myelomonocytic Leukemia (CMML).

Syed Nasir is an Oncologist practicing medicine in Towson, Maryland. Dr. Nasir is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. He is also highly rated in 85 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Lynch Syndrome, and Paget Disease of the Breast. Dr. Nasir is currently accepting new patients.

Eric Seifter is an Oncologist practicing medicine in Lutherville, Maryland. Dr. Seifter is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), and Richter Syndrome.

Ann Hester is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Hester is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Acute Kidney Failure, Lung Metastases, Sepsis, Endoscopy, and Colonoscopy.

Mark Soo Kim is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Soo Kim is rated as an Experienced provider by MediFind in the treatment of Acute Myelomonocytic Leukemia. His clinical expertise encompasses Type 2 Diabetes (T2D), Juvenile Idiopathic Arthritis (JIA), Sitosterolemia, and High Cholesterol.